Cocaine is often viewed as an elite drug, associated with movie stars, models, and other celebrities; however, the destructive consequences of cocaine addiction are anything but glamorous. Produced from the leaves of the South American coca plant, cocaine can be snorted as a powder, or diluted with liquid and injected into the bloodstream. In the form of crack, cocaine can be smoked for an intensified rush of energy. As a central nervous system stimulant, cocaine accelerates the activities of the brain, nerves, and heart, putting even healthy users at risk of heart attack or stroke.
Acamprosate, disulfiram and topiramate (a novel anticonvulsant sulphonated sugar) are also used to treat alcohol addiction. Acamprosate has shown effectiveness for patients with severe dependence, helping them to maintain abstinence for several weeks, even months. Disulfiram (also called Antabuse) produces a very unpleasant reaction when drinking alcohol that includes flushing, nausea and palpitations. It is more effective for patients with high motivation and some addicts use it only for high-risk situations. Patients who wish to continue drinking or may be likely to relapse, should not take disulfiram as it can result in the disulfiram-alcohol reaction mentioned previously, which is very serious and can even be fatal
Withdrawal. Medications and devices can help suppress withdrawal symptoms during detoxification. Detoxification is not in itself "treatment," but only the first step in the process. Patients who do not receive any further treatment after detoxification usually resume their drug use. One study of treatment facilities found that medications were used in almost 80 percent of detoxifications (SAMHSA, 2014). In November 2017, the Food and Drug Administration (FDA) granted a new indication to an electronic stimulation device, NSS-2 Bridge, for use in helping reduce opioid withdrawal symptoms. This device is placed behind the ear and sends electrical pulses to stimulate certain brain nerves. Also, in May 2018, the FDA approved lofexidine, a non-opioid medicine designed to reduce opioid withdrawal symptoms.
Each one of our drug and alcohol treatment centers offers a number of therapies and programs, including Partial Hospitalization Programs, Intensive Outpatient Programs, and Residential Treatment. Which program a patient chooses largely depends on their needs in rehab. Some thrive in an Outpatient setting, while others do best with the around-the-clock model that Residential Treatment provides. Effective treatment close to home gives people the flexibility they need to engage in a program that will meet their needs.
The hidden cost of alcoholism does not stop with health. Alcoholism is also linked to violent crime, resulting in a cost to the economy in terms of policing and prosecution. However, it is difficult to put a price on the impact that alcoholism has to society. A report by the IAS showed that a figure of £21 billion is regularly quoted by the Government in terms of the cost of alcohol to society (in England and Wales). This does not include the personal cost of alcoholism and only considers the cost that is imposed on others.
Remember though, overcoming alcoholism is a process. Less than half of individuals relapse after achieving one year of sobriety. That number reduces to less than 15 percent who relapse after five years of sobriety. For the greatest chance of long-term sobriety after completing an inpatient or outpatient program, you should participate in local support groups and continue with counseling. Treating alcoholism is an investment in your future. It will not only make a huge difference in your life, but also the lives of those around you such as family members and friends. Rehab Nightmare: Drugs, Chains and Canes - Full Documentary - BBC Africa Eye
Hospitalization Rehab, often known as a Partial Hospitalization Program, allows addicts to check into a treatment center or hospital for a certain number of hours each week. This is most similar to an outpatient rehab center, in that individuals will return to their home after their treatment program. However, in an outpatient clinic, patients may check in briefly and then leave.
Nalmefene, an opiate antagonist that is similar in its chemical structure to naltrexone, is one of the most recent drugs being investigated for the treatment of alcoholism. Like naltrexone (sold as ReVia, Depade, or Vivitrol), nalmefene deprives the person struggling with substance use of the pleasurable feelings associated with drinking. But nalmefene is less toxic to the liver than naltrexone. As of 2013, nalmefene was still undergoing clinical trials through the U.S. National Institutes of Health before receiving FDA approval. From Rehab to a Body Bag | Dying for Treatment: VICE Reports (Full Length)